Onyx Biotec IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE
For the Onyx Biotec IPO, the company is issuing shares at a pre-issue EPS of ₹2.54 and a post-issue EPS of ₹1.67. The pre-issue P/E ratio is 24.01x, while the post-issue P/E ratio is 36.52x against the Industry P/E ratio is 75.10x. The company's ROCE for FY24 is 10.58% and RoE for FY24 is 12.19%. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator |
|||||||||||
KPI | Values | ||||||||||
EPS Pre IPO (Rs.) | ₹2.54 | ||||||||||
EPS Post IPO (Rs.) | ₹1.67 | ||||||||||
P/E Pre IPO | 24.01 | ||||||||||
P/E Post IPO | 36.52 | ||||||||||
ROE | 12.19% | ||||||||||
ROCE | 10.58% | ||||||||||
P/BV | 1.99 | ||||||||||
Debt/Equity | 1.24 | ||||||||||
RoNW | 12.19% |
Equity Investment with CA Abhay
Stock Market Masterclass
FNO Stocks with CA Abhay
Option Trading with CA Abhay
Equity Trading with CA Abhay
Option Trading with CA Abhay
Equity Trading with CA Abhay
FNO Stocks with CA Abhay
Equity Investment with CA Abhay
Stock Market Masterclass
Copyright @2020 Design & Developed by Info Web Software